跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial
Approved
STANDARD
Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
5a412d1ecc6d22ba
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
5a412d1ecc6d22ba
Product Name
Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial
Artg Id
17905
Artg Name
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
1991-09-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e735478806165feec0852a36971dc4af.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a76086df442d92b70b55c1dd33bea61c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
5a412d1ecc6d22ba
Type
Standard
Back to TGA Approvals
Actilyse alteplase (rch) 50mg powder for injection vial with diluent vial - TGA Drug Approval Details
